APA

Parks B. W., Black L. L., Zimmerman K. A., Metz A. E., Steele C., Murphy-Ullrich J. E. & Kabarowski J. H. (20130930). CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury. : Journal of lipid research.

Chicago

Parks Brian W, Black Leland L, Zimmerman Kurt A, Metz Allison E, Steele Chad, Murphy-Ullrich Joanne E and Kabarowski Janusz H. 20130930. CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury. : Journal of lipid research.

Harvard

Parks B. W., Black L. L., Zimmerman K. A., Metz A. E., Steele C., Murphy-Ullrich J. E. and Kabarowski J. H. (20130930). CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury. : Journal of lipid research.

MLA

Parks Brian W, Black Leland L, Zimmerman Kurt A, Metz Allison E, Steele Chad, Murphy-Ullrich Joanne E and Kabarowski Janusz H. CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury. : Journal of lipid research. 20130930.